Skip to main content
15 December 2019
Last updated:
Friday 13 December 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us

Research Directory

  • Mitochondrial quality control as potential therapy

    Sunday 18 March 2018
    Interviewee/Contributor
    Paul Thompson
    Organisation
    Mission Therapeutics
    Drug discovery
    Strategy
    • Read more about Mitochondrial quality control as potential therapy

Organisations

  • Artios Pharma Ltd
  • Intercell AG
  • BioTop
  • Silence Therapeutics Plc
  • New Science Global Healthcare Fund
  • Novasecta
  • Verona Pharma Plc
  • Anergis SA
  • ImmunoGen Inc
  • Stanford University School of Medicine

Interviewees and Contributers

  • Martin Fussenegger
  • Angelika Joos
  • John Mayo
  • Alexa Machikas and Elena Kfoury
  • Dominique Constantini
  • Kevin Mooney
  • Edwin Moses
  • Tod Woolf
  • Jérôme Van Biervliet
  • Stefanos Theoharis

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Jacques Biton joins supervisory board at Nosopharm
Sunday December 8 2019
Norman Baylor joins science board at Valneva
Sunday December 8 2019
Vectura appoints Will Downie as CEO
Sunday December 8 2019
Santhera appoints Dario Eklund as CEO
Sunday December 8 2019
Robin Bhattacherjee is new CEO at Actimed
Sunday December 8 2019

© 2019 Evernow Publishing Ltd. Powered by Drupal.